Fieldpoint Private Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-1,823
Closed -$58K 18
2017
Q2
$58K Sell
1,823
-264
-13% -$8.32K 3% 17
2017
Q1
$68K Sell
2,087
-101,969
-98% -$3.21M 0.18% 62
2016
Q4
$3.21M Sell
104,056
-3,042
-3% -$92.9K 2.12% 17
2016
Q3
$3.44M Hold
107,098
2.3% 14
2016
Q2
$3.58M Sell
107,098
-116
-0.1% -$3.7K 2.44% 10
2016
Q1
$3.33M Hold
107,214
2.36% 15
2015
Q4
$3.28M Sell
107,214
-232
-0.2% -$7.3K 2.32% 18
2015
Q3
$3.2M Buy
107,446
+1,001
+0.9% +$32.1K 2.21% 21
2015
Q2
$3.39M Buy
106,445
+949
+0.9% +$30.9K 2.11% 19
2015
Q1
$3.48M Buy
105,496
+132
+0.1% +$4.2K 2.12% 22
2014
Q4
$3.11M Buy
105,364
+2,108
+2% +$60.4K 2.02% 22
2014
Q3
$2.9M Buy
103,256
+248
+0.2% +$6.96K 1.88% 25
2014
Q2
$2.9M Sell
103,008
-817
-0.8% -$23.3K 1.75% 26
2014
Q1
$3.16M Buy
103,825
+3,467
+3% +$103K 1.88% 20
2013
Q4
$2.92M Buy
100,358
+158
+0.2% +$4.6K 1.67% 26
2013
Q3
$2.73M Sell
100,200
-15,283
-13% -$416K 1.67% 24
2013
Q2
$3.07M Buy
+115,483
New +$3.19M 1.88% 27

Other funds holding PFE

Fieldpoint Private Advisors's PFE Position: Q3 2017 in Review

Fieldpoint Private Advisors sold out of Pfizer (PFE) in Q3 2017, closing a stake of 1,823 shares — an estimated $58K sold.

Fieldpoint Private Advisors first reported a position in PFE in Q2 2013 and held it in 17 quarters. The position peaked at $3.58M in Q2 2016. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • Fieldpoint Private Advisors reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
  • Fieldpoint Private Advisors sold 1,823 Pfizer shares in Q3 2017, an estimated $58K.
  • Fieldpoint Private Advisors first reported a position in Pfizer in Q2 2013 and held it in 17 quarters.
  • Fieldpoint Private Advisors's Pfizer position peaked at $3.58M in Q2 2016.
  • 2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Fieldpoint Private Advisors's 13F filing for Q3 2017.